{
  "actions": [
    {
      "acted_at": "2020-05-05", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2020-05-05", 
      "action_code": "H11100", 
      "committees": [
        "HLVC"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2020-05-05", 
      "action_code": "H11100", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr6731-116", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "G000559", 
      "district": "3", 
      "name": "Garamendi, John", 
      "original_cosponsor": true, 
      "sponsored_at": "2020-05-05", 
      "state": "CA", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "G000563", 
      "district": "7", 
      "name": "Gibbs, Bob", 
      "original_cosponsor": false, 
      "sponsored_at": "2020-05-19", 
      "state": "OH", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "H001088", 
      "district": "1", 
      "name": "Hagedorn, Jim", 
      "original_cosponsor": false, 
      "sponsored_at": "2020-05-19", 
      "state": "MN", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2020-05-05", 
  "number": "6731", 
  "official_title": "To require executive agencies to purchase pharmaceuticals from the United States, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Securing America's Pharmaceutical Supply Chain Act", 
  "sponsor": {
    "bioguide_id": "S001212", 
    "district": "8", 
    "name": "Stauber, Pete", 
    "state": "MN", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2020-05-05", 
  "subjects": [
    "Government operations and politics", 
    "Manufacturing", 
    "Prescription drugs", 
    "Public contracts and procurement", 
    "Trade agreements and negotiations"
  ], 
  "subjects_top_term": "Government operations and politics", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2020-05-05T04:00:00Z", 
    "text": "Securing America's Pharmaceutical Supply Chain Act\n\nThis bill allows an executive agency to purchase a drug approved or licensed by the Food and Drug Administration only if the drug is over 50% sourced, manufactured, and assembled in the United States.\n\nThis requirement may be waived (1) if the drug is not available in sufficient quantity or quality as over 50% sourced, manufactured, and assembled in the United States; or (2) during an emergency.\n\nThe U.S. Trade Representative (USTR) shall modify U.S. product coverage under all free trade agreements and the World Trade Organization Agreement on Government Procurement to exclude coverage of essential medicines and medical countermeasures. Subsequent to such modifications, the USTR shall make any necessary corresponding modifications of existing waivers and notify the Office of Management and Budget."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Securing America's Pharmaceutical Supply Chain Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Securing America\u2019s Pharmaceutical Supply Chain Act", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Securing America's Pharmaceutical Supply Chain Act", 
      "type": "display"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To require executive agencies to purchase pharmaceuticals from the United States, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2020-07-13T18:42:37Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr6731.xml"
}